A Randomized Study to Compare the Safety and Immunogenicity of Fluviral® Made With New Versus Aged Bulk

Inclusion Criteria: * Subjects who the investigator believes can and will comply with the requirements of the protocol should be enrolled in the study. * Male and female adults, 18 to 60 years. * Written informed consent obtained from the subject. * If the subject is female, she must be of non-childbearing potential or if she is of childbearing potential, she must practice adequate contraception for 30 days prior to vaccination, have a negative pregnancy test and continue such precautions for the duration of the study. Exclusion Criteria: * Acute disease at the time of enrollment. * Any confirmed or suspected immunosuppressive condition * Presence of blood dyscrasias, including hemaglobinopathies and myelo- or lymphoproliferative disorder. * Chronic administration of immunosuppressants or other immune-modifying drugs within six months prior to the first vaccine dose. * A history of any demyelinating disease including Guillain-Barré syndrome. * Presence of an active neurological disorder. * Any significant disorder of coagulation that increases the risk of intramuscular injections or treatment with coumadin derivatives or heparin. * Receipt of an influenza vaccine within 6 months prior to study enrollment. * Administration of any vaccines within 30 days prior to study enrollment or during the study period. * Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine(s) within 30 days preceding the vaccination or planned use during th…